Skip to main content
Erschienen in: International Journal of Colorectal Disease 9/2018

21.06.2018 | Original Article

Various clinicopathological features of patients with metachronous colorectal cancer in relation to different diagnostic intervals

verfasst von: Po-Yen Lin, Jy-Ming Chiang, Hsin-Yun Huang, Jeng-Fu You, Sum-Fu Chiang, Pao-Shiu Hsieh, Chien-Yuh Yeh, Rei-Ping Tang

Erschienen in: International Journal of Colorectal Disease | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Backgrounds

Clinicopathologic factors relating to developing metachronous colorectal cancer (CRC) have been reported. However, the effects of different diagnostic intervals on these risk factors required further analysis.

Patients and methods

This retrospective study comprised 14,481 patients diagnosed from January 1995 to December 2012. Metachronous CRC was defined as the occurrence of a second colorectal cancer at least 1 year post-operatively.

Results

A total of 153 (1.06%) patients developed metachronous CRCs during the follow-up. Significantly higher rates of developing metachronous cancer occurred in male patients (1.2 vs 0.9%), patients with synchronous CRC (2.0 vs 1.0%), and patients with a positive family history of CRC (1.4 vs 0.9%). Pertaining to diagnostic intervals related to clinicopathological features, more severe staging was significant in the diagnostic interval between 2 and 3 years (35 vs 7.7%, 20.6%, 17.5%, P = .01) compared with other intervals. Male patients were more frequently detected to have CRC within 3 years compared with females (53.1 vs 29.1%, P = .005). For a diagnostic interval ≧ 5 years, a significantly higher rate of metachronous CRC located at the right colon was observed than that located at the left colon (36.6 vs 19.7%, p = 0.03).

Conclusions

We evinced that a diagnostic interval between 2 and 3 years was a key time for metachronous CRC diagnosis with worse staging distribution. Based on current findings, we recommend the stratification of metachronous CRCs into diagnostic intervals of 1–2, 2–3, and ≧ 3 years, as they exhibit significantly different characteristics.
Literatur
1.
Zurück zum Zitat Bruinvels DJ, Stiggelbout AM, Kievit J, van Houwelingen HC, Habbema JD, van de Velde CJ (1994) Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 219(2):174–182CrossRefPubMedPubMedCentral Bruinvels DJ, Stiggelbout AM, Kievit J, van Houwelingen HC, Habbema JD, van de Velde CJ (1994) Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 219(2):174–182CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Ringland CL, Arkenau HT, O'Connell DL, Ward RL (2010) Second primary colorectal cancers (SPCRCs): experiences from a large Australian Cancer registry. Ann Oncol 21(1):92–97CrossRefPubMed Ringland CL, Arkenau HT, O'Connell DL, Ward RL (2010) Second primary colorectal cancers (SPCRCs): experiences from a large Australian Cancer registry. Ann Oncol 21(1):92–97CrossRefPubMed
3.
Zurück zum Zitat Mulder SA, Kranse R, Damhuis RA, Ouwendijk RJ, Kuipers EJ, van Leerdam ME (2012) The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up. Dis Colon Rectum 55(5):522–531CrossRefPubMed Mulder SA, Kranse R, Damhuis RA, Ouwendijk RJ, Kuipers EJ, van Leerdam ME (2012) The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up. Dis Colon Rectum 55(5):522–531CrossRefPubMed
4.
Zurück zum Zitat Cali RL, Pitsch RM, Thorson AG, Watson P, Tapia P, Blatchford GJ, Christensen MA (1993) Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 36(4):388–393CrossRefPubMed Cali RL, Pitsch RM, Thorson AG, Watson P, Tapia P, Blatchford GJ, Christensen MA (1993) Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 36(4):388–393CrossRefPubMed
5.
Zurück zum Zitat Papadopoulos V, Michalopoulos A, Basdanis G, Papapolychroniadis K, Paramythiotis D, Fotiadis P, Berovalis P, Harlaftis N (2004) Synchronous and metachronous colorectal carcinoma. Tech Coloproctol 8(suppl 1):s97–s100CrossRefPubMed Papadopoulos V, Michalopoulos A, Basdanis G, Papapolychroniadis K, Paramythiotis D, Fotiadis P, Berovalis P, Harlaftis N (2004) Synchronous and metachronous colorectal carcinoma. Tech Coloproctol 8(suppl 1):s97–s100CrossRefPubMed
6.
Zurück zum Zitat Rennert G, Robinson E, Rennert HS, Neugut AI (1995) Clinical characteristics of metachronous colorectal tumors. Int J Cancer 60:743–747CrossRefPubMed Rennert G, Robinson E, Rennert HS, Neugut AI (1995) Clinical characteristics of metachronous colorectal tumors. Int J Cancer 60:743–747CrossRefPubMed
7.
Zurück zum Zitat Evans HS, Møller H, Robinson D, Lewis CM, Bell CM, Hodgson SV (2002) The risk of subsequent primary cancers after colorectal cancer in Southeast England. Gut 50(5):647–652CrossRefPubMedPubMedCentral Evans HS, Møller H, Robinson D, Lewis CM, Bell CM, Hodgson SV (2002) The risk of subsequent primary cancers after colorectal cancer in Southeast England. Gut 50(5):647–652CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Yamazaki T, Takii Y, Okamoto H, Sakai Y, Hatakeyama K (1997) What is the risk factor for metachronous colorectal carcinoma? Dis Colon Rectum 40:935–938CrossRefPubMed Yamazaki T, Takii Y, Okamoto H, Sakai Y, Hatakeyama K (1997) What is the risk factor for metachronous colorectal carcinoma? Dis Colon Rectum 40:935–938CrossRefPubMed
9.
Zurück zum Zitat Togashi K, Konishi F, Ozawa A, Sato T, Shito K, Kashiwagi H, Okada M, Nagai H (2000) Predictive factors for detecting colorectal carcinomas in surveillance colonoscopy after colorectal cancer surgery. Dis Colon Rectum 43:S47–S53CrossRefPubMed Togashi K, Konishi F, Ozawa A, Sato T, Shito K, Kashiwagi H, Okada M, Nagai H (2000) Predictive factors for detecting colorectal carcinomas in surveillance colonoscopy after colorectal cancer surgery. Dis Colon Rectum 43:S47–S53CrossRefPubMed
10.
Zurück zum Zitat Park IJ, Yu CS, Kim HC, Jung YH, Han KR, Kim JC (2006) Metachronous colorectal cancer. Color Dis 8:323–327CrossRef Park IJ, Yu CS, Kim HC, Jung YH, Han KR, Kim JC (2006) Metachronous colorectal cancer. Color Dis 8:323–327CrossRef
11.
Zurück zum Zitat Balleste B, Bessa X, Pinol V et al (2007) Detection of metachronous neoplasms in colorectal cancer patients: identification of risk factors. Dis Colon Rectum 50:971–980CrossRefPubMed Balleste B, Bessa X, Pinol V et al (2007) Detection of metachronous neoplasms in colorectal cancer patients: identification of risk factors. Dis Colon Rectum 50:971–980CrossRefPubMed
12.
Zurück zum Zitat Leggett BA, Cornwell M, Thomas LR, Buttenshaw RL, Searle J, Young J, Ward M (1997) Characteristics of metachronous colorectal carcinoma occurring despite colonoscopic surveillance. Dis Colon Rectum 40:603–608CrossRefPubMed Leggett BA, Cornwell M, Thomas LR, Buttenshaw RL, Searle J, Young J, Ward M (1997) Characteristics of metachronous colorectal carcinoma occurring despite colonoscopic surveillance. Dis Colon Rectum 40:603–608CrossRefPubMed
13.
Zurück zum Zitat Chen HS, Sheen-Chen SM (2000) Synchronous and “early” metachronous colorectal adenocarcinoma: analysis of prognosis and current trends. Dis Colon Rectum 43:1093–1099CrossRefPubMed Chen HS, Sheen-Chen SM (2000) Synchronous and “early” metachronous colorectal adenocarcinoma: analysis of prognosis and current trends. Dis Colon Rectum 43:1093–1099CrossRefPubMed
14.
Zurück zum Zitat Gervaz P, Bucher P, Neyroud-Caspar I, Soravia C, Morel P (2005) Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: a population-based study. Dis Colon Rectum 48:227–232CrossRefPubMed Gervaz P, Bucher P, Neyroud-Caspar I, Soravia C, Morel P (2005) Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: a population-based study. Dis Colon Rectum 48:227–232CrossRefPubMed
15.
Zurück zum Zitat Kawai K, Ishihara S, Yamaguchi H, Sunami E, Kitayama J, Miyata H, Watanabe T (2015) Nomogram prediction of metachronous colorectal neoplasms in patients with colorectal cancer. Ann Surg 261(5):926–932CrossRefPubMed Kawai K, Ishihara S, Yamaguchi H, Sunami E, Kitayama J, Miyata H, Watanabe T (2015) Nomogram prediction of metachronous colorectal neoplasms in patients with colorectal cancer. Ann Surg 261(5):926–932CrossRefPubMed
16.
Zurück zum Zitat Lam AKY, Gopalan V, Carmichael R, Buettner PG, Leung M, Smith R, Lu CT, Ho YH, Siu S (2012) Metachronous carcinomas in colorectum and its clinicopathological significance. Int J Color Dis 27:1303–1310CrossRef Lam AKY, Gopalan V, Carmichael R, Buettner PG, Leung M, Smith R, Lu CT, Ho YH, Siu S (2012) Metachronous carcinomas in colorectum and its clinicopathological significance. Int J Color Dis 27:1303–1310CrossRef
17.
Zurück zum Zitat Fukutomi Y, Moriwaki H, Nagase S, Tajika M, Naito T, Miwa Y, Yamada Y, Araki H, Okuno M, Nagura K, Kato T, Ninomiya M (2002) Metachronous colon tumors: risk factors and rationale for the surveillance colonoscopy after initial polypectomy. J Cancer Res Clin Oncol 128(10):569–574CrossRefPubMed Fukutomi Y, Moriwaki H, Nagase S, Tajika M, Naito T, Miwa Y, Yamada Y, Araki H, Okuno M, Nagura K, Kato T, Ninomiya M (2002) Metachronous colon tumors: risk factors and rationale for the surveillance colonoscopy after initial polypectomy. J Cancer Res Clin Oncol 128(10):569–574CrossRefPubMed
18.
Zurück zum Zitat Battersby NJ, Coupland A, Bouliotis G, Mirza N, Williams JG (2014) Metachronous colorectal cancer: a competing risks analysis with consideration for a stratified approach to surveillance colonoscopy. J Surg Oncol 109(5):445–450CrossRefPubMed Battersby NJ, Coupland A, Bouliotis G, Mirza N, Williams JG (2014) Metachronous colorectal cancer: a competing risks analysis with consideration for a stratified approach to surveillance colonoscopy. J Surg Oncol 109(5):445–450CrossRefPubMed
19.
Zurück zum Zitat Hollington P, Tiong L, Young G (2011) Timing and detection of metachronous colorectal cancer. ANZ J Surg 81(4):272–274CrossRefPubMed Hollington P, Tiong L, Young G (2011) Timing and detection of metachronous colorectal cancer. ANZ J Surg 81(4):272–274CrossRefPubMed
20.
Zurück zum Zitat Jayasekara H, Reece JC, Buchanan DD, Rosty C, Dashti SG, Ait Ouakrim D, Winship IM, Macrae FA, Boussioutas A, Giles GG, Ahnen DJ, Lowery J, Casey G, Haile RW, Gallinger S, le Marchand L, Newcomb PA, Lindor NM, Hopper JL, Parry S, Jenkins MA, Win AK (2016) Risk factors for metachronous colorectal cancer following a primary colorectal cancer: a prospective cohort study. Int J Cancer 139(5):1081–1090CrossRefPubMedPubMedCentral Jayasekara H, Reece JC, Buchanan DD, Rosty C, Dashti SG, Ait Ouakrim D, Winship IM, Macrae FA, Boussioutas A, Giles GG, Ahnen DJ, Lowery J, Casey G, Haile RW, Gallinger S, le Marchand L, Newcomb PA, Lindor NM, Hopper JL, Parry S, Jenkins MA, Win AK (2016) Risk factors for metachronous colorectal cancer following a primary colorectal cancer: a prospective cohort study. Int J Cancer 139(5):1081–1090CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Lan YT, Lin JK, Li AF et al (2005) Metachronous colorectal cancer: necessity of post-operative colonoscopic surveillance. Int J Color Dis 20(2):121–125CrossRef Lan YT, Lin JK, Li AF et al (2005) Metachronous colorectal cancer: necessity of post-operative colonoscopic surveillance. Int J Color Dis 20(2):121–125CrossRef
22.
Zurück zum Zitat Maruyama H, Hasuike Y, Furukawa J, Naoi M, Takata N, Yayoi E, Okamura J, Okamoto S (1992) Multiple colorectal carcinomas and colorectal carcinoma associated with extracolonic malignancies. Surg Today 22(2):99–104CrossRefPubMed Maruyama H, Hasuike Y, Furukawa J, Naoi M, Takata N, Yayoi E, Okamura J, Okamoto S (1992) Multiple colorectal carcinomas and colorectal carcinoma associated with extracolonic malignancies. Surg Today 22(2):99–104CrossRefPubMed
Metadaten
Titel
Various clinicopathological features of patients with metachronous colorectal cancer in relation to different diagnostic intervals
verfasst von
Po-Yen Lin
Jy-Ming Chiang
Hsin-Yun Huang
Jeng-Fu You
Sum-Fu Chiang
Pao-Shiu Hsieh
Chien-Yuh Yeh
Rei-Ping Tang
Publikationsdatum
21.06.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Colorectal Disease / Ausgabe 9/2018
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-018-3106-7

Weitere Artikel der Ausgabe 9/2018

International Journal of Colorectal Disease 9/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.